Chronic Liver Disease is One of the Leading Causes of Death in Bangladesh: Experience by Death Audit from a Tertiary Hospital

Abstract

Background In industrialized countries, the audit has become an integral part of medical care. The experience from developing countries like Bangladesh is still inadequate. This study had been carried out to find out relation among some factors like age, sex, causes, diurenal variation, duration of hospital stay with death and errors in certification process.Materials and methods It was a cross-sectional study conducted at the Department of Medicine, Sir Salimullah Medical College (SSMC) and Mitford Hospital from March 2010 to August 2010. Information of consecutive 100 deaths was collected in a predesigned clinical data sheet within half an hour of every occurrence. Necessary data were collected from hospital case records (admission registrar, case files and death certificates) using structured checklist. Patients who were brought dead were excluded from the study.Results Among 100 deaths, 48% were males (n = 48) and 52% were females (n = 52). Within this group, 66.7% were males and 33.3% were females. First day (within 24 hours of admission) death accounted for 46% (n = 46) of all death and by the second day 23% (n = 23) of all deaths occurred. The highest underlying cause of death was cerebrovascular diseases (29% of total death), infectious disease contributed 20%, chronic liver disease 13%, malignancy 7%, poisoning 6%, cor pulmonale 5%, while others were 20%.Conclusion In this studychronic liver disease was found to be one of the leading causes of death in our hospital and most of them occurred due to hepatic encephalopathy. So, early detection of hepatic encephalopathy and treatment is necessary to reduce hospital mortality.How to cite this article: Abedin MF, Hoque MM, Islam ASMS, Chowdhury MFI, Das DC, Begum SA, Mamun AA, Mahtab MA, Rahman S, Saha AK. Chronic Liver Disease is One of the Leading Causes of Death in Bangladesh: Experience by Death Audit from a Tertiary Hospital. Euroasian J Hepato-Gastroenterol 2014;4(1):14-17.

Exploring the effectiveness of flavone derivatives for treating liver diseases: Utilizing DFT, molecular docking, and molecular dynamics techniques

“…Liver disease is a foremost cause of mortality worldwide, affecting approximately 100 million individuals in the USA alone. The American Liver Foundation states that the development of liver fibrosis and cirrhosis can be attributed to the damage, inflammation, and subsequent regeneration of liver parenchymal cells [1] , [2] , [3] . Despite extensive research on liver drugs, not all medications can effectively treat individual levels and complications of liver disease [4] .…”

Portal Vein Pulsatility Pattern in Cirrhotic Patients with Portal Hypertension: A Tool to Assess Severity of Liver Disease in a Low Setting Tertiary Hospital; A Cross-sectional Study

“…It is the fourteenth leading cause of death worldwide & one of the most signi cant causes of death in Bangladesh. [1], [2] According to the World Health Organization (WHO), cirrhosis is a diffuse condition marked by brosis and the transformation of normal liver architecture into nodules with aberrant structural characteristics. [3] Ascites, uid-electrolyte redistribution, hepatorenal syndrome, and hepatic encephalopathy are all symptoms of portal hypertension, which are severe sequelae of cirrhosis.…”